Acellular Pertussis Vaccines and Pertussis Resurgence: Revise or Replace?

Do we need a new vaccine to control the re-emergence of pertussis?

(2015) Kingston H.G. Mills et al.   TRENDS IN MICROBIOLOGY

Bordetella pertussis Proteins Dominating the Major Histocompatibility Complex Class II-Presented Epitope Repertoire in Human Monocyte-Derived Dendritic Cells

(2014) Rachel M. Stenger et al.   Clinical and Vaccine Immunology

Pertussis Resurgence: Perspectives From the Working Group Meeting on Pertussis on the Causes, Possible Paths Forward, and Gaps in Our Knowledge

(2014) D. L. Burns et al.   JOURNAL OF INFECTIOUS DISEASES

Changing Pertussis Epidemiology: Everything Old is New Again

(2014) T. A. Clark   JOURNAL OF INFECTIOUS DISEASES

A Phase I Clinical Study of a Live Attenuated Bordetella pertussis Vaccine - BPZE1; A Single Centre, Double-Blind, Placebo-Controlled, Dose-Escalating Study of BPZE1 Given Intranasally to Healthy Adult Male Volunteers

(2014) Rigmor Thorstensson et al.   PLoS One

Toward a new vaccine for pertussis

(2014) John B. Robbins et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Humoral and B-cell memory responses in children five years after pertussis acellular vaccine priming

(2014) Maria Carollo et al.   VACCINE

Antitoxins for diphtheria and tetanus decline more slowly after vaccination with DTwP than with DTaP: A study in a Chinese population

(2014) Yuyan Wu et al.   VACCINE

Global Population Structure and Evolution of Bordetella pertussis and Their Relationship with Vaccination

(2014) M. J. Bart et al.   mBio

The Virulence Factors of Bordetella pertussis: Talented Modulators of Host Immune Response

(2013) Giorgio Fedele et al.   ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS

Pertussis re-emergence in the post-vaccination era

(2013) Elena Chiappini et al.   BMC INFECTIOUS DISEASES

The Pertussis Problem

(2013) S. A. Plotkin   CLINICAL INFECTIOUS DISEASES

Immune Responses to Pertussis Vaccines and Disease

(2013) K. M. Edwards et al.   JOURNAL OF INFECTIOUS DISEASES

Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model

(2013) J. M. Warfel et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Different T cell memory in preadolescents after whole-cell or acellular pertussis vaccination

(2013) Kaatje Smits et al.   VACCINE

Relative Contribution of Th1 and Th17 Cells in Adaptive Immunity to Bordetella pertussis: Towards the Rational Design of an Improved Acellular Pertussis Vaccine

(2013) Pádraig J. Ross et al.   PLoS Pathogens

Pertussis: Challenges Today and for the Future

(2013) James D. Cherry   PLoS Pathogens

New pertussis vaccination approaches: en route to protect newborns?

(2012) Camille Locht et al.   FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY

Waning Protection after Fifth Dose of Acellular Pertussis Vaccine in Children

(2012) Nicola P. Klein et al.   NEW ENGLAND JOURNAL OF MEDICINE

Why Do Pertussis Vaccines Fail?

(2012) J. D. Cherry   PEDIATRICS

Pertussis Circulation Has Increased T-Cell Immunity during Childhood More than a Second Acellular Booster Vaccination in Dutch Children 9 Years of Age

(2012) Rose-Minke Schure et al.   PLoS One

Pregnant women in UK are offered whooping cough vaccine to protect newborns

(2012) M. Billingsley   BMJ-British Medical Journal

Attenuated Bordetella pertussis Vaccine Candidate BPZE1 Promotes Human Dendritic Cell CCL21-Induced Migration and Drives a Th1/Th17 Response

(2011) G. Fedele et al.   JOURNAL OF IMMUNOLOGY

Rationale for pertussis booster vaccination throughout life in Europe

(2011) Fred Zepp et al.   LANCET INFECTIOUS DISEASES

Long-term immunity against pertussis induced by a single nasal administration of live attenuated B. pertussis BPZE1

(2010) Pascal Feunou Feunou et al.   VACCINE

Cytokine and antibody profiles in 1-year-old children vaccinated with either acellular or whole-cell pertussis vaccine during infancy

(2009) V. Dirix et al.   VACCINE